Image Ben Hargreaves R&D Pharma gets ruthless as job losses mount across industry The industry is showing its teeth, as companies have started slashing positions. Market Access Weight loss treatments bring in billions but capacity remain... The high demand for weight loss treatments has made their rollout a staggered process. Digital Why healthcare is an easy target for cyberattacks The healthcare industry is getting hit more and more frequently by ransomware attacks. R&D Psychedelic treatments on cusp of approval, but questions re... There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy. Load more results
R&D Pharma gets ruthless as job losses mount across industry The industry is showing its teeth, as companies have started slashing positions.
Market Access Weight loss treatments bring in billions but capacity remain... The high demand for weight loss treatments has made their rollout a staggered process.
Digital Why healthcare is an easy target for cyberattacks The healthcare industry is getting hit more and more frequently by ransomware attacks.
R&D Psychedelic treatments on cusp of approval, but questions re... There is a new wave of psychedelic treatment moving through clinical trials targeting mental health conditions, and they are showing strong efficacy.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
